Disrupting tumor tissues by targeting fibroblast activation protein (FAP)

AU2026210789A1Pending Publication Date: 2026-08-20THE TRUSTEES OF THE UNIV OF PENNSYLVANIA
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026210789
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-07-30
Publication Date
2026-08-20

Smart Images

  • Figure 00000134_0000
    Figure 00000134_0000
  • Figure 00000135_0000
    Figure 00000135_0000
  • Figure 00000140_0000
    Figure 00000140_0000
Patent Text Reader

Abstract

Abstract The present invention relates to compositions and methods comprising a chimeric antigen receptor (CAR) capable of binding fibroblast activation protein (TAP) for use in treating diseases, disorders or conditions associated with the expression of TAP on canine, mouse, or human tumor-associated cells. Abstract
Need to check novelty before this filing date? Find Prior Art